Molecular basis for defective glycosylation and Pseudomonas pathogenesis in cystic fibrosis lung. - Wikidata - thesis-toulmin - TriplyDB

Molecular basis for defective glycosylation and Pseudomonas pathogenesis in cystic fibrosis lung.

Molecular basis for defective glycosylation and Pseudomonas pathogenesis in cystic fibrosis lung.

http://www.wikidata.org/entity/Q33950252

about

Infection, inflammation and host carbohydrates: a Glyco-Evasion Hypothesis Hyperacidification of cellubrevin endocytic compartments and defective endosomal recycling in cystic fibrosis respiratory epithelial cells Stable, site-specific fluorescent tagging constructs optimized for burkholderia species.Construction and characterization of stable, constitutively expressed, chromosomal green and red fluorescent transcriptional fusions in the select agents, Bacillus anthracis, Yersinia pestis, Burkholderia mallei, and Burkholderia pseudomallei Endosomal hyperacidification in cystic fibrosis is due to defective nitric oxide-cylic GMP signalling cascade Organelle acidification and disease.Synthetic peptide vaccine and antibody therapeutic development: prevention and treatment of Pseudomonas aeruginosa.Elevated furin levels in human cystic fibrosis cells result in hypersusceptibility to exotoxin A-induced cytotoxicity Proteomic biomarker discovery for the monogenic disease cystic fibrosis.Defective organellar acidification as a cause of cystic fibrosis lung disease: reexamination of a recurring hypothesis.Specificity in cancer immunotherapy.Revisiting the role of cystic fibrosis transmembrane conductance regulator and counterion permeability in the pH regulation of endocytic organelles.Disease-causing mutations in the cystic fibrosis transmembrane conductance regulator determine the functional responses of alveolar macrophages Golgi pH, its regulation and roles in human disease.Interleukin-1beta differentially regulates beta2 adrenoreceptor and prostaglandin E2-mediated cAMP accumulation and chloride efflux from Calu-3 bronchial epithelial cells. Role of receptor changes, adenylyl cyclase, cyclo-oxygenase 2, and protein ki Annexin A2 binds to endosomes following organelle destabilization by particulate wear debris.Unimpaired lysosomal acidification in respiratory epithelial cells in cystic fibrosis.Microarray analysis reveals induction of lipoprotein genes in mucoid Pseudomonas aeruginosa: implications for inflammation in cystic fibrosis.Cystic fibrosis transmembrane conductance regulator-independent phagosomal acidification in macrophages.Pharmacological modulation of cGMP levels by phosphodiesterase 5 inhibitors as a therapeutic strategy for treatment of respiratory pathology in cystic fibrosis.An advanced stochastic model for mucociliary particle clearance in cystic fibrosis lungs.TLR2 is mobilized into an apical lipid raft receptor complex to signal infection in airway epithelial cells.The vacuolating toxin of Helicobacter pylori mimicks the CFTR-mediated chloride conductance.Nonclassical pathway of Pseudomonas aeruginosa DNA-induced interleukin-8 secretion in cystic fibrosis airway epithelial cells.Glycolipid-Dependent, Protease Sensitive Internalization of Pseudomonas aeruginosa Into Cultured Human Respiratory Epithelial Cells.A soluble sulfogalactosyl ceramide mimic promotes Delta F508 CFTR escape from endoplasmic reticulum associated degradation pH of TGN and recycling endosomes of H+/K+-ATPase-transfected HEK-293 cells: implications for pH regulation in the secretory pathway.The direct and indirect effects of glycans on immune function.Cystic fibrosis transmembrane conductance regulator (CFTR)-mediated residual chloride secretion does not protect against early chronic Pseudomonas aeruginosa infection in F508del homozygous cystic fibrosis patients.End-organ dysfunction in cystic fibrosis: association with angiotensin I converting enzyme and cytokine gene polymorphisms.Nitrosative stress inhibits production of the virulence factor alginate in mucoidPseudomonas aeruginosa

P2860

Q27010099-E7107EC0-9C24-4DDB-9E93-78B7AE144611 Q28216541-E0BF1F78-608F-4BC9-BEC0-A72068D49F68 Q34290270-39571276-E8AD-42BE-A5EC-C2A57D467D71 Q34523864-76993A58-0332-4BAA-BC6C-CA5FABA55C3E Q34683157-87A53CC5-6FAF-4992-B391-10BA2A6D31D4 Q35057000-1F093A09-36A2-443A-B58B-AB8B7A94C530 Q35136110-C2C827DB-D9E6-49AE-A05E-AEFE1F208152 Q36072775-5F204F2E-9FCB-4284-BDD2-885D362C1497 Q36787231-F826297C-BFAB-4606-B7B5-BE62FC4787B7 Q37217993-84CA9DBF-8244-4714-8496-B75DF6EE519B Q37236636-30A750E1-05A9-4DD8-89DF-1AAB2E04E9B4 Q37246334-7AD55DAE-5FAE-4946-BED7-0B55D476AA2B Q37467748-76AAD8F7-A5FD-42C1-9F8C-70DCA3A81742 Q37876406-CD195221-B023-4FCF-AA83-B9A0A78ECC79 Q38327945-76835D49-0DD2-45FE-B27A-2A287D64B655 Q39236586-27465E49-1A85-4355-A159-BB978ED7424D Q39896675-03EE735C-602F-4871-B957-98DB27B82D3D Q40014245-8B4E8E59-2616-4D2F-9FD3-580A2408AF4C Q40088832-D946C331-67AD-4769-8807-4EECE1AF3A50 Q40116337-10017D87-0ACA-464F-9AC4-CCED20020AA6 Q40343365-210DDDA8-2F93-4304-AA20-11EC76B19126 Q40555493-EE0C4B99-EC67-43AD-AE7B-2270C4491184 Q40686303-8D6E1968-F1C1-417F-B0EC-2AA98A15986F Q41945526-5758C20C-3C4D-43D8-8592-9768C83FE0DD Q42216668-DE779B0F-0275-41FC-A9EF-002E7AFE6511 Q42688247-96E3AD5A-22D5-41ED-820E-029BBBE0CFDC Q44378719-3157099D-960A-4085-BFB2-5D065C11B290 Q46632825-679E0D45-0D45-4A6D-8254-0E572EDA9ED4 Q51644964-0FE0A88F-9BB3-4B34-AD18-F7FB950996C4 Q54792878-324BF962-FD5D-4C0B-8B17-14EA4AB90CE1 Q57036685-D61329CA-86CD-498B-98A8-EEB009E172B4

P2860

Molecular basis for defective glycosylation and Pseudomonas pathogenesis in cystic fibrosis lung.

http://www.wikidata.org/entity/Q33950252

description

2001 nî lūn-bûn

@nan

2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Molecular basis for defective ...... nesis in cystic fibrosis lung.

@ast

Molecular basis for defective ...... nesis in cystic fibrosis lung.

@en

type

label

Molecular basis for defective ...... nesis in cystic fibrosis lung.

@ast

Molecular basis for defective ...... nesis in cystic fibrosis lung.

@en

prefLabel

Molecular basis for defective ...... nesis in cystic fibrosis lung.

@ast

Molecular basis for defective ...... nesis in cystic fibrosis lung.

@en

P1433

Q33950252-F5FB17CD-852E-445E-B81E-DDD2EAB9838C

P1476

Q33950252-3321C1BE-CAD1-4396-B342-BE4D9687C38D

P2093

Q33950252-13F4D909-D3E4-4EFF-95D9-459E51D2DC7F

Q33950252-321EB929-EB95-4076-A2B4-DF1F8743A7C4

Q33950252-4796842D-3B00-4328-BC75-A549A829A0FA

Q33950252-714435E6-222F-4F22-BDBB-0C6219A57136

Q33950252-85949A3A-92DB-43DE-87FF-A3CCBBD59205

Q33950252-C70EA7F7-6F5B-4FAC-A4E6-55FF8E73BBD8

P2860

Q33950252-068DA1CF-774B-407C-97FA-10EDBD7F3608

Q33950252-0C0DA06E-BF6F-4398-9DC3-141367834E59

Q33950252-10B2468B-01C0-4EFF-AC15-2830FA78D253

Q33950252-17E737A3-5508-450B-BB51-8FF9B331288A

Q33950252-1B0A9C6A-406A-4052-AB7B-7677A9CA43A7

Q33950252-1E06BCF0-D777-4901-A57E-8517746EA293

Q33950252-37DE01FF-EC0F-4EE3-AC23-17CD349E3A0A

Q33950252-3BAD5613-5183-4F32-9529-82F49F243F3A

Q33950252-3E12F1A7-175A-4959-B2E8-8E4249A176CC

Q33950252-4610423D-8950-4778-92C6-9A89A14DB766

P304

Q33950252-2A0693CE-0365-4168-A006-105713BA3C4C

P31

Q33950252-9BA80613-BE62-4CAA-AC61-DDF10616EE4C

P356

Q33950252-14D3BB99-5328-4C4E-A3FE-7963F26AAE93

P407

Q33950252-B18CA944-CCD0-4CB8-A604-86D56468FB18

P433

Q33950252-95770EB5-B7F6-4366-9CFD-81ABBB013482

P478

Q33950252-369DC772-E378-4E8F-9222-FFD50C94952C

P577

Q33950252-921A0A04-0A3E-4988-8F6E-16C4A2FC603B

P5875

Q33950252-C0F3FC39-DD72-42CC-8FD4-414BEBA04DBA

P698

Q33950252-4CB7DD8A-AD6F-422D-844E-0ABAC743B807

P921

Q33950252-7BA7015D-C7A6-442F-B200-718B0C07BD4C

Q33950252-E440C3A9-0C3A-4B98-8FD6-4B0A932D8719

P932

Q33950252-235FD596-F7F6-4A10-B308-B6D83A1680A9

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Molecular basis for defective ...... nesis in cystic fibrosis lung.

@en

P2093

J C Boucher

http://www.w3.org/2001/XMLSchema#string

J F Poschet

http://www.w3.org/2001/XMLSchema#string

J Skidmore

http://www.w3.org/2001/XMLSchema#string

L Tatterson

http://www.w3.org/2001/XMLSchema#string

R W Van Dyke

http://www.w3.org/2001/XMLSchema#string

V Deretic

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease

CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATP

Innate lung defenses and compromised Pseudomonas aeruginosa clearance in the malnourished mouse model of respiratory infections in cystic fibrosis

Visualizing secretion and synaptic transmission with pH-sensitive green fluorescent proteins

Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis

Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface

Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia

Terminal sialylation is altered in airway cells with impaired CFTR-mediated chloride transport.

Cystic fibrosis and the salt controversy.

Many pulmonary pathogenic bacteria bind specifically to the carbohydrate sequence GalNAc beta 1-4Gal found in some glycolipids

P304

13972-13977

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.241182598

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

98

http://www.w3.org/2001/XMLSchema#string

P577

2001-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11638833

http://www.w3.org/2001/XMLSchema#string

P698

11717455

http://www.w3.org/2001/XMLSchema#string

P921

cystic fibrosis

P932

61151

http://www.w3.org/2001/XMLSchema#string